Advertisement

Topics

Terumo to develop and commercialise Orchestra BioMed’s Virtue SEB

14:12 EDT 14 Jun 2019 | Compelo Medical Devices

Terumo has received exclusive global development and commercialization rights to Orchestra BioMed’s Virtue SEB for percutaneous coronary interventions. Virtue SEB is claimed to be the first and only

The post Terumo to develop and commercialise Orchestra BioMed’s Virtue SEB appeared first on NS Medical Devices.

Original Article: Terumo to develop and commercialise Orchestra BioMed’s Virtue SEB

NEXT ARTICLE

More From BioPortfolio on "Terumo to develop and commercialise Orchestra BioMed’s Virtue SEB"

Advertisement
Quick Search
Advertisement
Advertisement